by European Public Health Alliance | May 4, 2016 | Opinion
Under pressure from health-harmful lobbies, how EU decisions are made is changing fundamentally. Lobbyists are finding new ways to ensure that these cases are never closed in favour of health protection. Not just Volkswagen who decided to cheat rather than comply with...
by European Public Health Alliance | May 3, 2016 | Opinion
The Dutch Presidency makes moves to shake the medicines accessibility and affordability landscape, questioning the suitability of patents, market exclusivities and monopolies, and announcing draft Council Conclusions on medicines. By Yannis Natsis, @ynatsis Policy...
by EPHA | May 3, 2016 | Opinion
By Sascha Marschang, Policy Manager for Health Systems, EPHA A recent conference in London, ’Antibiotics and Farming: Prescriptions for Change’ organised by the Alliance to Save our Antibiotics and Medact, explored the link between farming practices and drug-resistant...
by EPHA | May 3, 2016 | Opinion
By Sascha Marschang, Policy Manager for Health Systems, EPHA The new ’VulnerABLE’ Project aims to increase our understanding of how best to improve the health of people who are living in vulnerable and isolated situations in the European Union. It began in early 2016... by European Public Health Alliance | May 3, 2016 | Opinion
EPHA believes that greater transparency is vital to ensure proper democratic and public debate about the impact of trade policy on population health, following Greenpeace Netherlands’ release of classified TTIP negotiating documents By Zoltán Massay-Kosubek, Policy...
by European Public Health Alliance | May 3, 2016 | Opinion
Restricting the use of transfats in the food system will quickly yield significant and directly observable results. Removing trans fats from products is not only possible, but has been done by many small and big food companies alike. Why are we still waiting for the...